Effect of Resveratrol-Based Nutritional Supplement on Choroidal Thickness: A Pilot Study

References

• Langcake P, Pryce RJ. A new class of phytoalexins from grapevines. Experientia 1977;33(2):151–152.
   PubMedGoogle Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discovery 2006;5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275(5297):218–220.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Lekli I, Gurusamy N, Bertelli AA, Das DK. Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med 2009;46(5):573–578.
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest Ophthalmol Vis Sci 2007;48(9):4232–4239.
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Martini F, Cavarzeran F, Pilotto E, Midena E. Macular and peripapillary choroidal thickness in diabetic patients. Retina 2012;32(9):1781–1790.
   PubMed Web of Science ®Google Scholar
• Kang HM, Kwon HJ, Yi JH, Lee CS, Lee SC. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration. Am J Ophthalmol 2014;157(5):1013–1021.
   PubMed Web of Science ®Google Scholar
• Kim DY, Silverman RH, Chan RV, Khanifar AA, Rondeau M, Lloyd H, et al. Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra (R)). Acta Ophthalmol 2013;91(2):183–188.
   PubMed Web of Science ®Google Scholar
• Zengin MO, Cinar E, Kucukerdonmez C. The effect of nicotine on choroidal thickness. Br J Ophthalmol 2014;98(2):233–237.
   PubMed Web of Science ®Google Scholar
• Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010;91(6):1590–1597.
   PubMed Web of Science ®Google Scholar
• Shen M, Zhao L, Wu RX, Yue SQ, Pei JM. The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms. Vasc Pharmacol 2013;58(1–2):64–70.
   PubMed Web of Science ®Google Scholar
• Gordish KL, Beierwaltes WH. Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging. Am J Physiol Renal Physiol 2014;306(5);542–550.
   Web of Science ®Google Scholar
• Wong RH, Howe PR, Buckley JD, Coates AM, Kunz I, Berry NM. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 2011;21(11):851–856.
   PubMed Web of Science ®Google Scholar
• Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996;27(2):363–366.
   PubMedGoogle Scholar
• Bertini S, Calderone V, Carboni I, Maffei R, Martelli A, Martinelli A, et al. Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties. Bioorg Med Chem 2010;18(18):6715–6724.
   PubMed Web of Science ®Google Scholar
• Yoo MY, Oh K-S, Lee JW, Seo HW, Yon GH, Kwon DY, et al. Vasorelaxant effect of stilbenes from rhizome extract of rhubarb (Rheum undulatum) on the contractility of rat aorta. Phytother Res 2007;21(2):186–189.
   PubMed Web of Science ®Google Scholar
• Wong RH, Berry NM, Coates AM, Buckley JD, Bryan J, Kunz I, et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens 2013;31(9):1819–1827.
   PubMed Web of Science ®Google Scholar
• Richer S, Patel S, Sockanathan S, Ulanski LJ 2nd, Miller L, Podella C. Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients. Nutrients 2014 Oct 17;6(10):4404–20.
   Google Scholar
• Richer S, Stiles W, Ulanski L, Carroll D, Podella C. Observation of human retinal remodeling in octogenarians with a resveratrol-based nutritional supplement. Nutrients 2013;5(6):1989–2005.
   PubMed Web of Science ®Google Scholar
• Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res 2011;4(9):1419–25.
   PubMed Web of Science ®Google Scholar
• De Santi C1, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 2000;30(9):857–66.
   PubMed Web of Science ®Google Scholar
• Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, et al. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 2011;31(11):842–7.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Vitamin D: a custodian of cell signalling stability in health and disease. Biochem Soc Trans 2015;43(3):349–58.
   PubMed Web of Science ®Google Scholar
• Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010;150(3):325–329.
   PubMed Web of Science ®Google Scholar
• Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci 2013;54(5):3378–3384.
   PubMed Web of Science ®Google Scholar
• Han JM, Hwang JM, Kim JS, Park KH, Woo SJ. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study. Invest Ophthalmol Vis Sci 2014;55(1):440–445.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang ZT, Zhang H. Comparison of choroidal thickness measured by two methods. Int J Ophthalmol 2012;5(3):348–353.
   PubMed Web of Science ®Google Scholar
• Lutty GA, Cao J, McLeod DS. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 1997;151(3):707–714.
   PubMed Web of Science ®Google Scholar
• Nickla DL, Wallman J. The multifunctional choroid. Prog Retinal Eye Res 2010;29(2):144–168.
   PubMed Web of Science ®Google Scholar
• Bailey V. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina 2011;31(2):332–335.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart and Circulatory Physiol 2009;297(5):H1876–H1881.
   PubMed Web of Science ®Google Scholar
• Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 2008;138(09):1602–1608.
   PubMed Web of Science ®Google Scholar
• Anger EM, Unterhuber A, Hermann B, Sattmann H, Schubert C, Morgan JE, et al. Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections. Exp Eye Res 2004;78(6):1117–1125.
   Google Scholar
• McCulley TJ, Luu JK, Marmor MF, Feuer WJ. Effects of sildenafil citrate (Viagra) on choroidal congestion. Ophthalmologica 2002;216(6):455–458.
   PubMed Web of Science ®Google Scholar
• Maul EA, Friedman DS, Chang DS, Boland MV, Ramulu PY, Jampel HD, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118(8):1571–1579.
   PubMed Web of Science ®Google Scholar
• Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol 2011;152(4):663–668.
   PubMed Web of Science ®Google Scholar
• Dheeraj B-P. Reproducibility-repeatability of choroidal thickness calculation using optical coherence tomography. Optom Vis Sci 2010;87(11):867–872.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Yamashita T, Shirasawa M, Arimura N, Terasaki H, Sakamoto T. Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices. Invest Ophthalmol Vis Sci 2012;53(3):1102–1107.
   PubMed Web of Science ®Google Scholar
• Rahman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L. Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52(5):2267–2271.
   PubMed Web of Science ®Google Scholar
• Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol 2009;147(5):801–810.
   PubMed Web of Science ®Google Scholar
• Bola C, Bartlett H, Eperjesi F. Resveratrol and the eye: activity and molecular mechanisms. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur Klinische und Experimentelle. Ophthalmologie 2014;252(5):699–713.
   PubMed Web of Science ®Google Scholar
• Xu W, Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Martin ER, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol 2010;150(1):40–47.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim YS, Roh GS, Choi WS, Cho GJ. Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol 2012;90(1):e31–37.
   Google Scholar
• Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics and effect on the insulin-like growth factor axis. Cancer Res 2010;70(22):9003–9011.
   PubMed Web of Science ®Google Scholar
• Vaz-da-Silva M, Loureiro AL, Falcao A, Nunes T, Rocha J-F, Fernandes-Lopes C, et al. Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther 2008;46(11):564–570.
   PubMed Web of Science ®Google Scholar
• Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 2009;53(Suppl. 1):S7–15.
   PubMedGoogle Scholar
• Jarratt RA, Bartlett H, Eperjesi F. Retinal effects of resveratrol. US Ophthal Rev 2013;6(2):132–134.
   Google Scholar
• David M., Goldberg JY, George JS. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003;36(01):79–87.
   PubMed Web of Science ®Google Scholar
• Nunes T, Almeida L, Rocha JF, Falcao A, Fernandes-Lopes C, Loureiro AI, et al. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J Clin Pharmacol 2009;49(12):1477–1482.
   PubMed Web of Science ®Google Scholar
• Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, et al. Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharml Sci 2004;93(10):2448–2457.
   PubMed Web of Science ®Google Scholar
• Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007;16(6):1246–1252.
   PubMed Web of Science ®Google Scholar
• Burkon A, Somoza V. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides—two novel resveratrol metabolites in human plasma. Mol Nutr Food Res 2008;52(5):549–557.
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003;36(1):79–87.
   PubMed Web of Science ®Google Scholar
• Bertelli A, Bertelli AAE, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998;24(03):133–138.
   PubMedGoogle Scholar